Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae
During the last two decades, microalgae have attracted increasing interest, both commercially and scientifically. Commercial potential involves utilizing valuable natural compounds, including carotenoids, polysaccharides, and polyunsaturated fatty acids, which are widely applicable in food, biofuel,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-06-01
|
| Series: | Marine Drugs |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1660-3397/20/7/434 |
| _version_ | 1797417360903110656 |
|---|---|
| author | Omayra C. Bolaños-Martínez Ganesan Mahendran Sergio Rosales-Mendoza Sornkanok Vimolmangkang |
| author_facet | Omayra C. Bolaños-Martínez Ganesan Mahendran Sergio Rosales-Mendoza Sornkanok Vimolmangkang |
| author_sort | Omayra C. Bolaños-Martínez |
| collection | DOAJ |
| description | During the last two decades, microalgae have attracted increasing interest, both commercially and scientifically. Commercial potential involves utilizing valuable natural compounds, including carotenoids, polysaccharides, and polyunsaturated fatty acids, which are widely applicable in food, biofuel, and pharmaceutical industries. Conversely, scientific potential focuses on bioreactors for producing recombinant proteins and developing viable technologies to significantly increase the yield and harvest periods. Here, viral-based vectors and transient expression strategies have significantly contributed to improving plant biotechnology. We present an updated outlook covering microalgal biotechnology for pharmaceutical application, transformation techniques for generating recombinant proteins, and genetic engineering tactics for viral-based vector construction. Challenges in industrial application are also discussed. |
| first_indexed | 2024-03-09T06:17:40Z |
| format | Article |
| id | doaj.art-57f7c36f49734e1e87155f4b054a8346 |
| institution | Directory Open Access Journal |
| issn | 1660-3397 |
| language | English |
| last_indexed | 2024-03-09T06:17:40Z |
| publishDate | 2022-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Marine Drugs |
| spelling | doaj.art-57f7c36f49734e1e87155f4b054a83462023-12-03T11:51:34ZengMDPI AGMarine Drugs1660-33972022-06-0120743410.3390/md20070434Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic MicroalgaeOmayra C. Bolaños-Martínez0Ganesan Mahendran1Sergio Rosales-Mendoza2Sornkanok Vimolmangkang3Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandLaboratorio de Biofarmacéuticos Recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, MexicoDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDuring the last two decades, microalgae have attracted increasing interest, both commercially and scientifically. Commercial potential involves utilizing valuable natural compounds, including carotenoids, polysaccharides, and polyunsaturated fatty acids, which are widely applicable in food, biofuel, and pharmaceutical industries. Conversely, scientific potential focuses on bioreactors for producing recombinant proteins and developing viable technologies to significantly increase the yield and harvest periods. Here, viral-based vectors and transient expression strategies have significantly contributed to improving plant biotechnology. We present an updated outlook covering microalgal biotechnology for pharmaceutical application, transformation techniques for generating recombinant proteins, and genetic engineering tactics for viral-based vector construction. Challenges in industrial application are also discussed.https://www.mdpi.com/1660-3397/20/7/434biopharmaceuticalsrecombinant proteinstransient expressionviral vectors |
| spellingShingle | Omayra C. Bolaños-Martínez Ganesan Mahendran Sergio Rosales-Mendoza Sornkanok Vimolmangkang Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae Marine Drugs biopharmaceuticals recombinant proteins transient expression viral vectors |
| title | Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae |
| title_full | Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae |
| title_fullStr | Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae |
| title_full_unstemmed | Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae |
| title_short | Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae |
| title_sort | current status and perspective on the use of viral based vectors in eukaryotic microalgae |
| topic | biopharmaceuticals recombinant proteins transient expression viral vectors |
| url | https://www.mdpi.com/1660-3397/20/7/434 |
| work_keys_str_mv | AT omayracbolanosmartinez currentstatusandperspectiveontheuseofviralbasedvectorsineukaryoticmicroalgae AT ganesanmahendran currentstatusandperspectiveontheuseofviralbasedvectorsineukaryoticmicroalgae AT sergiorosalesmendoza currentstatusandperspectiveontheuseofviralbasedvectorsineukaryoticmicroalgae AT sornkanokvimolmangkang currentstatusandperspectiveontheuseofviralbasedvectorsineukaryoticmicroalgae |